Eqis Capital Management, Inc. Dr Reddys Laboratories LTD Transaction History

Eqis Capital Management, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $186,589 - $233,399	-3,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$62.12 - $74.2 $192,572 - $230,020	3,100 New	3,100 $228,000
Q1 2021 May 14, 2021	SELL	$57.98 - $73.08 $353,793 - $445,934	-6,102 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$62.61 - $71.29 $248,686 - $283,163	-3,972 Reduced 39.43%	6,102 $435,000
Q3 2020 Nov 10, 2020	BUY	$51.39 - $72.41 $517,702 - $729,458	10,074 New	10,074 $701,000

Q4 2019 Jan 24, 2020	SELL	$36.66 - $41.78 $197,047 - $224,567	-5,375 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$34.82 - $39.26 $313 - $353	9 Added 0.17%	5,375 $204,000
Q2 2019 Jul 18, 2019	SELL	$36.05 - $42.76 $334,976 - $397,325	-9,292 Reduced 63.39%	5,366 $201,000
Q1 2019 Apr 18, 2019	BUY	$35.77 - $40.57 $94,110 - $106,739	2,631 Added 21.88%	14,658 $594,000
Q4 2018 Jan 25, 2019	BUY	$31.89 - $38.44 $28,445 - $34,288	892 Added 8.01%	12,027 $453,000
Q3 2018 Oct 17, 2018	BUY	$29.25 - $36.73 $31,268 - $39,264	1,069 Added 10.62%	11,135 $393,000
Q2 2018 Jul 27, 2018	SELL	$28.49 - $35.06 $20,484 - $25,208	-719 Reduced 6.67%	10,066 $324,000
Q1 2018 Apr 06, 2018	SELL	$31.93 - $39.54 $862 - $1,067	-27 Reduced 0.25%	10,785 $353,000
Q4 2017 Jan 25, 2018	SELL	$34.15 - $37.62 $8,093 - $8,915	-237 Reduced 2.14%	10,812 $406,000
Q3 2017 Oct 03, 2017	BUY	$30.11 - $37.72 $332,685 - $416,768	11,049	11,049 $394,000

242

23.6M

25.2K

8.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.